We need your support. Know More

US FDA Denies Emergency Use Approval to Bharat Biotech's Covaxin

The Wire Staff
Jun 11, 2021
This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.

This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.

Bharat Biotech has also filed a Rs 100 crore defamation case against The Wire, its editors, and 10 staffers and contributors.

The Wire will be fighting this injunction and defamation plaint.

Make a contribution to Independent Journalism